ClinicalTrials.gg
RecruitingNCT06843174PROMISEUpdated Oct 30, 2026

Perioperative Rectal Methadone in Spine Surgery

A Phase 4 interventional study of Rectal Methadone administer during spinal surgery and Placebo: Rectal saline solution in Spinal Surgery, Post-operative Care and Post-operative Pain Management, sponsored by Unity Health Toronto. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Unity Health Toronto · Phase 4, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 9 months later.
Updated Oct 30, 2026Primary completion movedStudy completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 190 studies in Pain, Postoperative with a site in Canada — 38 open to participants now, 42 under way, 3 of them phase 3. Pain, Postoperative · Canada.

Planned enrollment
135th of 175
40 · median 82
Started
2025
with 11 others
Phase 4
38 of 190
8 open now
Primary completion
2027-03
later than 26 of 41 live
Registered
181st of 190
by date

Among the 190 studies in Pain, Postoperative with a site in Canada, this one is the 135th largest by planned enrollment of the 175 interventional ones that give a count, is one of 12 that started in 2025, is one of 38 in phase 4, reaches primary completion later than 26 of the 41 other live ones, and was the 181st registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

38 of the 190 studies in Pain, Postoperative with a site in Canada are open now. Recruiting first, the newest first:

32 more — sign in →

All 38 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 190 studies in Pain, Postoperative with a site in Canada, or all of them as a file.
02

Study summary

Patients undergoing spinal surgery require pain control medication after their surgery. Investigators have successfully used intravenous Methadone to manage pain after surgery. However, doctors in Canada do not have the intravenous form of Methadone to prescribe to their patients. The investigators in Canada propose a pilot trial to investigate whether Methadone administered rectally could be used to manage pain after spinal surgery.

The main questions are:

  1. Are investigators able to recruit participants for this trial and learn from this study to plan a larger trial?
  2. Does Methadone administered rectally during surgery, reduce participants' pain intensity, use less pain medication, and have a better recovery after surgery? Investigators will compare Methadone to a placebo (a look-alike substance that contains no drug) to see if Methadone works to manage pain after surgery better than the usual pain management.

Participants will:

  • receive either Methadone or placebo during surgery.
  • be asked some questions about their pain during days 1 to 3 after surgery
  • be contacted by phone to ask about their recovery

At this time, the study aims to recruit 40 participants from St. Michael's Hospital, to learn whether it will be feasible to plan a larger study.

Read the detailed description

Indication: Adult patients undergoing spine surgery Condition: Perioperative pain management Number of participants 40 Primary outcome Feasibility (recruitment success, consent rate, adherence, patient withdrawal, missing data, adverse outcomes) Secondary outcome 1) Average pain intensity; 2) Rate of respiratory depression and postoperative ileus; 3) Use of opioids in morphine equivalents; 4) Quality of recovery Study design

  • Interventional trial
  • Allocation: Randomized
  • Intervention model: 2-Arm Parallel-Group
  • Primary purpose: Feasibility
  • Phase: Phase IV

Masking Participants and Outcome Assessors

Study Intervention:

  • Intervention Arm: Methadone 0.2mg/kg of ideal body weight via rectal administration + standard or care
  • Placebo Arm: Saline solution via rectal administration + standard of care

Follow-Up: Postoperative days 1, 2, 3, and 30

03

Conditions studied

  • Spinal Surgery
  • Post-operative Care
  • Post-operative Pain Management

Browse trials for

Keywords

  • Intraoperative Methadone
  • Rectal Methadone administration
  • spinal surgery post-operative pain management
04

Who can participate

The criteria were revised on the registry on Oct 30, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. 18 years old or older
  2. Elective spinal surgery with fusion of one or more sacral, lumbar, thoracic, and/or cervical levels
  3. Capacity to provide
  4. For participants of , use of .

Exclusion criteria

Exclusion Criteria:

  1. Physical Status > IV
  2. to the active substance (methadone hydrochloride) or other opioid analgesics or to any ingredient in the formulation
  3. Pregnant or nursing participants
  4. Known or suspected mechanical gastrointestinal obstruction
  5. Acute respiratory depression, elevated carbon dioxide levels in the blood, cor pulmonale, or pulmonary disease necessitating home oxygen therapy
  6. Acute alcohol intoxication, delirium tremens, and convulsive disorders secondary to alcohol intoxication
  7. Severe central nervous system depression, increased intracranial pressure, or head injury
  8. Use of monoamine oxidase (MAO) inhibitors, such as isocarboxazid, phenelzine, selegiline, and tranylcypromine, within 14 days of enrollment
  9. Diarrhea associated with pseudomembranous colitis caused by cephalosporins, lincomycins, or penicillins
  10. Preoperative renal insufficiency or failure
  11. Significant liver disease (cirrhosis or hepatic failure)
  12. History of opioid use disorder within the last 3 months
  13. Patients taking more than 90 mg of morphine equivalents daily
  14. Poor comprehension of the English language
  15. Patients who are likely to remain intubated postoperatively
  16. > 500ms on preoperative
Terms in these criteria, in plain language(7)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Childbearing potential

Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).

Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

QT and QTc

On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.

The study may name a correction formula and a limit in milliseconds, often around 450–480.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Phase
Phase 4
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Intervention Arm with Methadone

    During the spinal surgery intervention, participants receive a single dose of 0.2mg/kg of Methadone rectally, after anesthesia induction.

    Drug: Rectal Methadone administer during spinal surgery

  • Placebo comparator
    Placebo arm

    During the spinal surgery intervention, participants receive a single dose of saline solution rectally after anesthesia induction.

    Other: Placebo: Rectal saline solution

Interventions

  • DrugRectal Methadone administer during spinal surgery

    Rectal Methadone administered during spinal surgery for post-operative pain management

  • OtherPlacebo: Rectal saline solution

    Placebo: Rectal saline solution single dose received during surgery

06

What researchers measure

Primary outcomes

  1. Feasibility to recruit 40 participants into a trial of methadone and placebo

    Recruitment rate (Acceptability and feasibility study)

    Time frame: 18 months

  2. Feasibility to recruit 40 participants into a trial of methadone and placebo

    Withdrawal rate (Acceptability and feasibility study)

    Time frame: 18 months

Secondary outcomes

  1. Adverse outcomes

    Rate of postoperative respiratory depression

    Time frame: At 24, 48, and 72 hours post operative

  2. Adverse outcomes

    Rate of postoperative ileus

    Time frame: At 24, 48, and 72 hours post operative

  3. Opioid reduction

    Total morphine equivalent used

    Time frame: At 24, 48, and 72 hours post operative

  4. Pain intensity after surgery

    Patient-Reported Outcomes Measurement Information System Pain Interference (PROMIS) Pain Intensity, Pain intensity scale- 0 to 10 (The higher the number the higher the pain intensity)

    Time frame: At 24, 48, and 72 hours post operative

  5. Quality of Recovery

    Quality of Recovery (QoR-15) Score, 15 items are rated on a 0-10 scale, with the total possible score ranging from 0 to 150, where higher scores indicate better recovery.

    Time frame: At 24, 48, and 72 hours post operative

  6. Pain interference

    Patient-Reported Outcomes Measurement Information System Pain Interference, PROMIS 6 a. 6 items, 5 Likert scale (the higher the score the higher the interference from pain)

    Time frame: Difference between Baseline and 30 days after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Dale O, Sheffels P, Kharasch ED. Bioavailabilities of rectal and oral methadone in healthy subjects. Br J Clin Pharmacol. 2004 Aug;58(2):156-62. doi: 10.1111/j.1365-2125.2004.02116.x. PubMed 15255797 ↗
  • Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur MA, Vender JS, Benson J, Newmark RL. Clinical Effectiveness and Safety of Intraoperative Methadone in Patients Undergoing Posterior Spinal Fusion Surgery: A Randomized, Double-blinded, Controlled Trial. Anesthesiology. 2017 May;126(5):822-833. doi: 10.1097/ALN.0000000000001609. PubMed 28418966 ↗
  • Machado FC, Vieira JE, de Orange FA, Ashmawi HA. Intraoperative Methadone Reduces Pain and Opioid Consumption in Acute Postoperative Pain: A Systematic Review and Meta-analysis. Anesth Analg. 2019 Dec;129(6):1723-1732. doi: 10.1213/ANE.0000000000004404. PubMed 31743194 ↗
  • Murphy GS, Avram MJ, Greenberg SB, Shear TD, Deshur MA, Dickerson D, Bilimoria S, Benson J, Maher CE, Trenk GJ, Teister KJ, Szokol JW. Postoperative Pain and Analgesic Requirements in the First Year after Intraoperative Methadone for Complex Spine and Cardiac Surgery. Anesthesiology. 2020 Feb;132(2):330-342. doi: 10.1097/ALN.0000000000003025. PubMed 31939849 ↗
  • Machado FC, Palmeira CCA, Torres JNL, Vieira JE, Ashmawi HA. Intraoperative use of methadone improves control of postoperative pain in morbidly obese patients: a randomized controlled study. J Pain Res. 2018 Oct 2;11:2123-2129. doi: 10.2147/JPR.S172235. eCollection 2018. PubMed 30323647 ↗
  • Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg. 2011 Jan;112(1):218-23. doi: 10.1213/ANE.0b013e3181d8a095. Epub 2010 Apr 24. PubMed 20418538 ↗
  • Elliott K, Kest B, Man A, Kao B, Inturrisi CE. N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development. Neuropsychopharmacology. 1995 Dec;13(4):347-56. doi: 10.1016/0893-133X(95)00083-P. PubMed 8747759 ↗
  • Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R. Opioid complications and side effects. Pain Physician. 2008 Mar;11(2 Suppl):S105-20. PubMed 18443635 ↗
  • American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology. 2012 Feb;116(2):248-73. doi: 10.1097/ALN.0b013e31823c1030. No abstract available. PubMed 22227789 ↗
  • Weir S, Samnaliev M, Kuo TC, Ni Choitir C, Tierney TS, Cumming D, Bruce J, Manca A, Taylor RS, Eldabe S. The incidence and healthcare costs of persistent postoperative pain following lumbar spine surgery in the UK: a cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES). BMJ Open. 2017 Sep 11;7(9):e017585. doi: 10.1136/bmjopen-2017-017585. PubMed 28893756 ↗
  • Gerbershagen HJ, Aduckathil S, van Wijck AJ, Peelen LM, Kalkman CJ, Meissner W. Pain intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology. 2013 Apr;118(4):934-44. doi: 10.1097/ALN.0b013e31828866b3. PubMed 23392233 ↗
  • Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017 Sep 25;10:2287-2298. doi: 10.2147/JPR.S144066. eCollection 2017. PubMed 29026331 ↗
  • Puvanesarajah V, Liauw JA, Lo SF, Lina IA, Witham TF, Gottschalk A. Analgesic therapy for major spine surgery. Neurosurg Rev. 2015 Jul;38(3):407-18; discussion 419. doi: 10.1007/s10143-015-0605-7. Epub 2015 Feb 14. PubMed 25680636 ↗

Individual participant data

Plan to share: No — This is a feasibility pilot trial only.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2025 (actual). Primary completion is estimated for Mar 2027, 25 months after the start.

Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 25 months is above that.

Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 30, 2026: primary completion Jul 2026 → Mar 2027 and completion Aug 2026 → Mar 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 11, 2025
First posted
Feb 24, 2025
StartActual
Feb 19, 2025
Primary completionEst.
Mar 2027was Jul 2026
CompletionEst.
Mar 2027was Aug 2026
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jul 2026→Mar 2027
Oct 30, 2026
Study completion
Aug 2026→Mar 2027
Oct 30, 2026
Eligibility
Maximum age 65 Years→none; 1 inclusion criterion edited
What changed in the criteria
Inclusion criteria
  • Edited18 to 65 years-old.years old or older
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    Primary completion Jul 2026→Mar 2027
    Study completion Aug 2026→Mar 2027
    Eligibility Maximum age 65 Years→none; 1 inclusion criterion edited
    What changed in the criteria
    Inclusion criteria
    • Edited18 to 65 years-old.years old or older
    + 4 other changes: index terms, verification date, oversight details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06843174
Collaborators
AFP Innovation Fund
Responsible party
Sponsor
First posted
Feb 24, 2025
Start date
Feb 19, 2025
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Oct 30, 2026

Study contacts

Sergio Pereira, MD PhD
Contact
Sergio.Pereira@unityhealth.to
416-360-4000 ext. 49308
Janneth A Pazmino-Canizares, MSc
Contact
Janneth.Pazmino-Canizares@unityhealth.to
4168646060 ext. 49561
Sergio Pereira, MD PhD
principal investigator · St. Michael's Hospital. Unity Health Toronto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion